Work

supplemental figures from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase

Year: 2023

Type: supplementary-materials

Abstract: Suppl. Figure 1. Determination of sensitivity, specificity and accuracy using ROC curves. Suppl. Figure 2. CSF levels of D-2HG and WHO grade of IDH mutant gliomas Suppl. Figure 3. CSF D-2HG levels and gender/age. Suppl. Figure 4. D- and L-2HG levels in CSF drawn at different locations in WT and mutant IDH glioma patients. Suppl. Figure 5. Comparison of NMR and MS for the detection of D-2HG in tumor tissue and CSF.

DOI: 10.1158/1078-0432.22467506.v1

Authors: Juliya Kalinina, Jun Ahn, Narra S. Devi, Liya Wang, Yuancheng Li, Jeffrey J. Olson, Michael Glantz, Thomas Smith, Ella L. Kim, Alf Giese, Randy L. Jensen, Clark C. Chen, Bob S. Carter, Hui Mao, Miao He, Erwin G. Van Meir

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361931111

Cites:

Cited by:

Related to: 10